Disease Caused by Antibodies Directed Against Normal Components of the Glomerular Basement Membrane

Slide 1 · Disease Caused by Antibodies Directed Against Normal Components of the Glomerular Basement Membrane

Anti-GBM glomerulonephritis • crescentic injury • pulmonary–renal correlation

Pathology teaching lecture

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Locate the anti-GBM antigen within the glomerular filtration barrier.

Explain why anti-GBM disease gives continuous linear immunofluorescence.

Connect antibody-mediated capillary injury to crescents and rapidly progressive glomerulonephritis.

Distinguish renal-limited anti-GBM disease from Goodpasture syndrome.

Integrate pathology, serology, and urgent management principles.

Slide 3 · The defining triad of anti-GBM disease

Target

Fixed basement-membrane antigen

Type IV collagen NC1 domain

Tissue pattern

Linear GBM IgG

Often necrotizing or crescentic GN

Clinical expression

Rapidly progressive renal injury

Pulmonary hemorrhage in a subset

One pathogenic autoantibody explains the target, immunofluorescence pattern and organ injury.

Slide 4 · Why this mechanism is distinctive

Antibodies react with normal, intrinsic glomerular constituents rather than nonspecific trapped complexes.

Target antigens extend along the GBM, so immunoglobulin labeling traces capillary basement membranes continuously.

The disease is uncommon among all glomerulonephritides but important within the RPGN syndrome.

Clinical identification matters because circulating antibodies can be physically removed.

Slide 5 · The glomerular filtration barrier: Relevant layers

Capillary blood and endothelium

Lamina rara interna

Lamina densa: Type IV collagen network

Lamina rara externa

Podocytes and urinary space

A continuous intrinsic antigen-bearing surface differs from discrete immune-complex deposits.

Schematic • layers simplified; Not an electron micrograph

Slide 6 · Why the basement membrane matters

The GBM separates fenestrated capillary endothelium from the podocyte epithelial layer.

Its scaffold includes type IV collagen, laminin, proteoglycans and additional matrix proteins.

Integrity of the barrier limits leakage of proteins and formed blood elements into urine.

Anti-GBM antibodies target a constituent of this structural barrier.

Slide 7 · Three molecular features of type IV collagen

Triple-helical region

Central collagenous segment

Participates in basement-membrane scaffold

NC1 domain

Noncollagenous C terminus

Contains the target epitope in anti-GBM disease

α chains

Six genetically distinct chain types

α3 chain implicated in Goodpasture antigen

NC1 is part of the normal GBM molecule, not a circulating immune-complex particle.

Slide 8 · The common antigen in kidney and lung

Collagen type IV

α3 chain

C-terminal NC1 region

Recognized by pathogenic autoantibody

The same target is shared by glomerular and pulmonary alveolar basement membranes. Renal-limited and pulmonary–renal presentations reflect different organ involvement.

Slide 9 · A fixed antigen distributed along the GBM

Capillary blood and endothelium

Lamina rara interna

Lamina densa: Type IV collagen network

Lamina rara externa

Podocytes and urinary space

Autoantibodies bind fixed targets throughout the type IV collagen–rich GBM.

Schematic • layers simplified; Not an electron micrograph

Slide 10 · Anti-GBM disease is antibody mediated

Circulating autoantibodies bind their target in situ in the glomerular basement membrane.

Antibody engagement is followed by inflammatory injury to the capillary wall.

Severe injury can rupture GBM segments and initiate extracapillary crescent formation.

Immunoglobulin localization is a defining histopathologic clue.

Slide 11 · From antibody binding to rapidly progressive injury

Anti-GBM autoantibody

Binding to intrinsic GBM antigen

Glomerular inflammatory injury

GBM disruption and crescents

Rapid GFR decline

The immune trigger and the morphologic response are distinct: The former defines disease type, whereas the latter reflects the severity of glomerular damage.

Slide 12 · Two ways antibodies can localize in the glomerulus

Fixed intrinsic GBM antigen

Target is a native structural molecule.

Autoantibody binds directly along a continuous surface.

Anti-GBM nephritis is the prototype.

Linear IF is characteristic.

Immune-complex deposition

Antigen and antibody form discrete complexes.

Complexes may form locally or circulate before deposition.

Mesangial or capillary wall deposits.

Granular IF is typical.

Slide 13 · Do not confuse in situ binding with immune complexes

“In situ” describes the location where the antibody meets the antigen.

Both direct anti-GBM binding and some immune-complex diseases can involve local antibody–antigen interaction.

The spatial distribution of accessible target antigen drives the IF pattern.

Anti-GBM disease is defined by reactivity against an intrinsic GBM component.

Slide 14 · Why anti-GBM immunofluorescence is linear

Target distributed along GBM

Antibodies bind throughout capillary loops

Continuously localized IgG

Smooth linear GBM fluorescence

The observed pattern reflects *where the target exists*, rather than the amount of cellular proliferation in the glomerulus.

Slide 15 · Immunofluorescence: The linear anti-GBM pattern

Continuous linear IgG

Schematic of capillary-wall immunoreactivity; Not a clinical immunofluorescence image.

Slide 16 · Immunofluorescence: Granular immune-complex pattern

Discrete granular deposits

Schematic of capillary-wall immunoreactivity; Not a clinical immunofluorescence image.

Slide 17 · Immunofluorescence: Pauci-immune pattern

Little/no Ig signal

Schematic of capillary-wall immunoreactivity; Not a clinical immunofluorescence image.

Slide 18 · Three immunofluorescence patterns compared

Continuous linear IgG

Discrete granular deposits

Little/no Ig signal

Schematic of capillary-wall immunoreactivity; Not a clinical immunofluorescence image.

Slide 19 · Interpret the fluorescence pattern mechanistically

IF appearance

Mechanism suggested

Example

Continuous linear GBM

Antibody bound to fixed GBM antigen

Anti-GBM GN

Granular deposits

Discrete immune complexes

Immune-complex GN

Absent / very scant

Few immune reactants detected

Pauci-immune GN

C3-dominant

Complement-dominant glomerular injury

C3 glomerulopathy

Pattern guides classification but must be interpreted alongside light microscopy and clinical findings.

Slide 20 · The three complementary biopsy modalities

Light microscopy

Cellular proliferation

Necrosis and crescents

Distribution and chronic scarring

Immunofluorescence

Linear versus granular Ig/complement

Classification of immune injury

Electron microscopy

Identify immune-complex deposits

Recognize GBM disruption

A crescent is a lesion pattern; Immunofluorescence helps establish its cause.

Slide 21 · Light microscopy: What a crescent signifies

Severe glomerular capillary wall injury can provoke extracapillary cellular proliferation.

Proliferating epithelial cells accumulate within Bowman space.

Monocytes/macrophages and fibrin frequently contribute to the lesion.

Expansion of the crescent compresses the glomerular capillary tuft.

Slide 22 · Crescent architecture in Bowman space

Crescent: Epithelial cells and macrophages

Compressed capillary loops

Bowman capsule

Schematic — not a histologic specimen

Slide 23 · How GBM rupture promotes crescent formation

Inflammatory capillary damage

GBM rupture

Plasma proteins and coagulation factors enter urinary space

Epithelial/macrophage response

Crescent formation

Fibrin and coagulation mediators are implicated, but the detailed mechanism of crescent induction is not fully established.

Slide 24 · Cellular composition of crescents

Proliferating glomerular epithelial cells form a major cellular component.

Infiltrating monocytes and macrophages contribute to extracapillary accumulation.

Fibrin strands can lie between cellular layers.

Neutrophils and lymphocytes may be present in some cases.

Slide 25 · Cellular versus fibrous crescents

Cellular crescent

Recent or active extracapillary proliferation.

Numerous cells occupy Bowman space.

Can compress capillary loops.

A marker of significant acute injury.

Fibrous crescent

Organization of a prior lesion.

Represents healed/chronic scarring.

Suggests injury present for some time or recurring.

May accompany slower disease progression.

Slide 26 · Fibrinoid necrosis and glomerular destruction

Necrosis can accompany severe capillary-wall injury in crescentic GN.

Segmental disruption allows plasma components to enter Bowman space.

Extracapillary fibrin supports recognition of severe inflammatory damage.

Necrosis is not exclusive to anti-GBM disease: Other causes of crescentic GN may show it.

Slide 27 · Distribution terms used in a renal biopsy

Diffuse: Most or all glomeruli are affected in the sampled tissue.

Focal: Only a subset of glomeruli is affected.

Global: An entire individual glomerulus is affected.

Segmental: Only part of an individual tuft is involved.

These terms describe spatial extent, not the underlying antigen.

Slide 28 · Gross appearance versus diagnostic specificity

Macroscopic changes

Kidneys may be pale and enlarged in crescentic GN.

Cortical petechial hemorrhages may occur.

Not specific to anti-GBM antibody disease.

Microscopic evidence

Crescents and necrosis reflect severe injury.

Linear glomerular IgG supports anti-GBM pathogenesis.

Serology adds direct evidence of circulating antibody.

Slide 29 · Electron microscopy: What to look for

Immune-complex GN can show discrete electron-dense deposits.

In severe crescentic disease, GBM ruptures may be seen on ultrastructural examination.

Anti-GBM disease is not defined by the discrete immune-complex deposits typical of type II crescentic GN.

Interpret EM together with IF and light microscopy.

Slide 30 · Renal lesion to clinical syndrome

GBM and capillary wall injury

Red cells and proteins enter filtrate

Hematuria and proteinuria

Inflammation lowers GFR

Azotemia and oliguria

Clinical abnormalities are consequences of a damaged filtration barrier plus loss of functional glomerular filtration area.

Slide 31 · RPGN: A clinical syndrome, not one diagnosis

Rapidly progressive glomerulonephritis is characterized by severe glomerular injury.

Renal function deteriorates over a short interval, often with oliguria.

Crescents are the usual histologic accompaniment.

Anti-GBM, immune-complex, and pauci-immune mechanisms can all produce RPGN.

Slide 32 · The nephritic clinical pattern

Urinary

Hematuria

Red blood cell casts

Proteinuria

Filtration

Falling GFR

Oliguria

Azotemia

Hemodynamic

Edema

Fluid retention

Variable hypertension

The combination of hematuria, kidney dysfunction and rapid change should prompt investigation for RPGN.

Slide 33 · Why red blood cells appear in urine

Inflammatory GBM damage

Capillary wall becomes permeable to erythrocytes

Glomerular hematuria

RBC casts may form in tubules

Casts link the urinary finding to intrarenal, usually glomerular, bleeding; They are part of the nephritic presentation.

Slide 34 · Why oliguria and azotemia develop

Capillary injury and proliferative response

Reduced glomerular filtration

Reduced urine formation

Creatinine/BUN rise

Oliguria may be accompanied by salt and water retention, edema and variable hypertension.

Slide 35 · Immunologic classification of crescentic GN

Type

Defining immune finding

Representative conditions

I — anti-GBM

Linear GBM immunoglobulin; C3 may accompany

Renal-limited anti-GBM disease; Goodpasture syndrome

II — immune complex

Granular immunoglobulin/complement

Postinfectious GN, lupus nephritis, IgA nephropathy

III — pauci-immune

Little or no immunoreactant deposition

ANCA-associated GN; renal-limited pauci-immune GN

Identical crescent morphology can arise from mechanistically different immune diseases.

Slide 36 · Type I crescentic GN: Anti-GBM pattern

Circulating antibody recognizes a native basement-membrane epitope.

IF typically demonstrates linear GBM IgG; C3 is present in many cases.

Renal-limited disease and Goodpasture syndrome share the same core mechanism.

Plasma exchange is rational because the offending antibody circulates in plasma.

Slide 37 · Type II crescentic GN: Discrete immune complexes

Immune complexes are deposited in glomeruli and can provoke intense inflammation.

Immunofluorescence is granular rather than the anti-GBM linear pattern.

Representative settings include lupus nephritis, infection-associated GN and IgA nephropathy.

Treatment targets the underlying cause; Plasma exchange is generally not useful merely because the lesion has crescents.

Slide 38 · Type III crescentic GN: Pauci-immune lesions

Immunofluorescence and EM show little or no glomerular immune-complex deposition.

Often associated with circulating MPO-ANCA or PR3-ANCA.

May involve systemic vasculitis or be confined to the kidneys.

Severe necrosis and crescents can look similar by light microscopy to anti-GBM disease.

Slide 39 · Anti-GBM versus ANCA versus immune complex

Observation

Anti-GBM

Pauci-immune / ANCA

Immune complex

IF pattern

Linear IgG

Scant / absent

Granular

EM deposits

No characteristic granular deposits

No characteristic immune deposits

Discrete electron-dense deposits

RPGN possible?

Yes

Yes

Yes

Clinical tests

Serum anti-GBM

MPO-/PR3-ANCA

Etiology-directed serology

RPGN is the presenting syndrome; Immunopathology separates its main etiologic groups.

Slide 40 · A source-grounded diagnostic sequence

Acute nephritic picture + falling GFR

Serum anti-GBM and ANCA testing

Renal biopsy: LM, IF, EM

Classify immune pattern

Identify renal/pulmonary involvement

Serology and biopsy are complementary; The urgency follows from the risk of rapid irreversible renal dysfunction.

Slide 41 · Role and limitations of serologic markers

Serum anti-GBM antibody testing supports direct antibody-mediated disease.

MPO-ANCA and PR3-ANCA guide assessment of pauci-immune vasculitic mechanisms.

ANA and related autoimmune investigations help evaluate alternative immune-complex etiologies.

A serologic result should be interpreted with the biopsy pattern and clinical setting.

Slide 42 · How immunofluorescence directs interpretation

What is the glomerular IF pattern?

Linear GBM IgG

Anti-GBM mechanism is favored; Correlate with circulating anti-GBM antibody.

Granular deposits

Consider immune-complex causes; Assess clinical and serologic context.

Scant deposits

Consider pauci-immune GN; Assess MPO-/PR3-ANCA.

The diagram is a teaching heuristic, not a substitute for complete renal pathology evaluation.

Slide 43 · Why linear IF is not a complete clinical diagnosis

Establishes a strong mechanism clue

A continuous basement-membrane pattern of immunoglobulin localization.

Compatible with antibody to a fixed intrinsic GBM antigen.

Particularly persuasive in crescentic GN.

Must still assess

Serum anti-GBM antibody.

Extent and activity of necrosis/crescents.

Pulmonary hemorrhage and renal dysfunction.

Alternative or concurrent immune patterns.

Slide 44 · Renal-limited anti-GBM and Goodpasture syndrome

Kidney

Glomerular basement membrane

Nephritic syndrome / RPGN

Linear GBM IgG

Lung

Alveolar basement membrane

Hemorrhagic pulmonary injury

Hemoptysis may dominate

Goodpasture syndrome denotes pulmonary hemorrhage accompanying anti-GBM renal disease.

Slide 45 · Goodpasture syndrome: Terminology matters

Anti-GBM disease can be restricted clinically to the kidneys.

When antibody-related alveolar injury causes pulmonary hemorrhage with renal disease, “Goodpasture syndrome.”

The shared autoantigen is the α3-chain NC1 region of type IV collagen.

Renal-limited disease should not automatically be called pulmonary–renal syndrome.

Slide 46 · The same antigen explains two organ phenotypes

Circulating anti-α3(IV) NC1 antibody

Binding to susceptible basement membranes

Kidney: Crescentic GN

Lung: Alveolar hemorrhage

Pulmonary involvement is not universal. It is a clinical expression of the shared antigen, not a separate unrelated antibody disease.

Slide 47 · Pulmonary lesions in Goodpasture syndrome

Pulmonary capillary/alveolar basement membrane injury allows intra-alveolar bleeding.

Early lesions may show necrosis of alveolar walls.

Hemosiderin-laden macrophages can accumulate following hemorrhage.

Later phases may show septal fibrosis and type II pneumocyte hyperplasia.

Slide 48 · Clinical clues to pulmonary hemorrhage

Hemoptysis and radiographic pulmonary infiltrates can precede overt renal findings.

Some patients develop recurrent bleeding or life-threatening pulmonary hemorrhage.

The renal process may simultaneously present with rapidly rising azotemia.

A renal biopsy showing linear GBM IgG places the lung findings in a coherent mechanism.

Slide 49 · Kidney findings versus lung findings

Kidney

Necrotizing / crescentic GN with severe injury.

Hematuria and red cell casts.

Proteinuria with oliguria and azotemia.

Linear GBM IgG by immunofluorescence.

Lung

Diffuse alveolar hemorrhage may occur.

Hemoptysis or respiratory symptoms.

Hemosiderin macrophages after bleeding.

Alveolar basement membrane injury.

Slide 50 · Susceptibility and possible initiating factors

The stimulus that triggers anti-GBM autoantibody production remains uncertain.

Genetic associations involving selected HLA-DRB1 alleles.

Exposure to viral agents or hydrocarbon solvents has been implicated in some patients.

These associations do not establish a single proven initiating cause.

Slide 51 · Clinical epidemiology: What Robbins supports

Anti-GBM antibody GN represents a small minority of all GN, described as less than 5%.

It nevertheless contributes materially to crescentic/RPGN presentations.

Goodpasture cases are described especially in younger individuals, with a male predominance.

Pulmonary involvement is associated with smoking in textbook descriptions; Population estimates vary by setting.

Slide 52 · Why treatment addresses two pathogenic levels

Remove antibody

Plasma exchange

Reduces circulating anti-GBM antibody

Suppress formation

Immunosuppressive therapy

Limits further autoimmune antibody production

Protect organs

Treat renal failure

Manage pulmonary hemorrhage

Monitor evolving clinical course

Removing a circulating mediator and suppressing its replenishment are complementary strategies.

Slide 53 · Plasma exchange: Mechanism and clinical logic

Circulating pathogenic autoantibody

Therapeutic plasma exchange

Lower antibody burden

Reduced ongoing GBM/alveolar exposure

Plasma exchange as a central component of therapy in anti-GBM/Goodpasture disease; It does not replace immunosuppression.

Slide 54 · Immunosuppression complements antibody removal

Autoreactive immune response

Steroid + cytotoxic immunosuppression

Reduced new autoantibody generation

Control of ongoing inflammation

Early, intensive combined therapy as potentially reversing pulmonary bleeding and preserving renal function in responsive cases.

Slide 55 · Potentially reversible versus chronic injury

Early active injury

Cellular crescent and acute inflammation.

Potential for recovery with rapid treatment.

Clinical function may improve if irreversible damage is limited.

Established damage

Fibrous crescents and segmental scarring.

Structural restoration is less likely.

Some patients require chronic dialysis or transplantation.

Slide 56 · From persistent injury to chronic renal impairment

Severe glomerular destruction

Organization of crescents

Segmental scars / glomerulosclerosis

Nephron loss

Progressive renal dysfunction

Late presentation can leave structural damage even when the initiating immune process is addressed.

Slide 57 · Case 1: Rapidly progressive renal presentation

Hypothetical adult: Recent hematuria, oliguria and rapidly worsening renal function.

Urinary sediment contains red blood cell casts.

Biopsy demonstrates crescents and smooth linear GBM IgG staining.

What is the most likely pathogenic mechanism? What blood test directly supports it?

Slide 58 · Case 1: Mechanism and confirmation

Mechanism

Autoantibodies directed against fixed GBM antigen

Type I crescentic GN

Targeted serology

Measure serum anti-GBM antibody

Also assess relevant RPGN differentials

Why urgency?

Rapid reduction of GFR

Risk of progression to irreversible damage

Linear IF links the clinical RPGN syndrome to an antibody directed at intrinsic GBM.

Slide 59 · Case 2: Pulmonary–renal syndrome

Hypothetical adult: Hemoptysis and pulmonary infiltrates followed by hematuria.

Renal function deteriorates over days to weeks.

Kidney biopsy shows necrotizing crescentic GN with linear capillary-loop IgG.

Which shared structural antigen can account for both organs?

Slide 60 · Case 2: Unified pulmonary–renal diagnosis

Kidney

Crescentic GN

Linear GBM IgG

Renal filtration failure

Lung

Alveolar hemorrhage

Hemoptysis

Shared basement-membrane antigen

Goodpasture syndrome is the pulmonary–renal manifestation of anti-GBM antibody disease.

Slide 61 · Case 3: A crescent is not enough

Hypothetical biopsy: Glomerular crescents and necrotizing lesions.

IF reveals little or no immune-reactant staining.

Serology identifies a circulating MPO-ANCA.

Why is this not classified as anti-GBM type I disease?

Slide 62 · Case 3: Distinguish lesion from etiology

Shared histologic pattern

Necrosis and crescents.

Severe nephritic/RPGN presentation.

Capillary wall disruption.

Distinct pathogenic evidence

Pauci-immune: Little or no IF deposition.

ANCA supports a different immune mechanism.

Anti-GBM: Expected linear GBM IgG.

Slide 63 · High-yield morphology–mechanism correlations

Pathology finding

Interpretation

Key limitation

Linear GBM IgG

Antibody to intrinsic GBM target

Integrate with serology

Crescents

Severe extracapillary response

Not cause-specific

Segmental necrosis

Severe tuft injury

Occurs across RPGN types

Granular IF / deposits

Immune-complex mechanism

Evaluate antigenic cause

Fibrous crescents

Chronic/healed injury

Less reversible component

Never assign the cause of RPGN from the crescent alone.

Slide 64 · Anti-GBM disease: Five diagnostic anchors

1. Target

α3(IV) NC1 collagen domain

2. IF

Linear glomerular IgG

3. LM

Necrosis and/or crescents

4. Clinical

RPGN; Hematuria ± pulmonary bleeding

5. Serum anti-GBM antibodies integrate the immune mechanism with biopsy and clinical findings.

Slide 65 · Selected primary-source references

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th edition (2026). Chapter 20, “The Kidney,” pp. 815–820, 825–827.

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th edition (2026). Chapter 15, “The Lung,” pp. 642–643: Goodpasture syndrome.

Teaching diagrams are original editable schematics based on the indicated textbook descriptions; they are not diagnostic photomicrographs.